Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2018 Filed May 3, 2018 20:56 UTC |
BAILLAVOINE BRUNO JEAN-MARIEDirector
|
GrantOptions · Derivative | 80,000 | $0.01 Strike: $2.45 | $800.00 |
DisclosureSEC source: 0001236031-18-000022 · primary_doc.xml · derivative · entry 1 BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,500 Underlying: Common Stock · 80,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:50 UTC |
YOUNG PETER RDirector
|
GrantOptions · Derivative | 80,000 | $0.01 Strike: $2.45 | $800.00 |
DisclosureSEC source: 0001236031-18-000021 · primary_doc.xml · derivative · entry 1 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,200 Underlying: Common Stock · 80,000 shares Expires 2028-04-30 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:46 UTC |
CIPRIANO JOHNSenior Vice President
|
GrantOptions · Derivative | 135,000 | $0.01 Strike: $2.45 | $1,350.00 |
DisclosureSEC source: 0001236031-18-000020 · primary_doc.xml · derivative · entry 2 CIPRIANO JOHN · CIK 0001282304 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,547 Underlying: Common Stock · 135,000 shares Expires 2028-04-30 F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:46 UTC |
CIPRIANO JOHNSenior Vice President
|
GrantOptions · Derivative | 13,347 | $0.01 Strike: $2.45 | $133.47 |
DisclosureSEC source: 0001236031-18-000020 · primary_doc.xml · derivative · entry 1 CIPRIANO JOHN · CIK 0001282304 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,547 Underlying: Common Stock · 13,347 shares Expires 2028-04-30 F1 · shares: The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:41 UTC |
ZIMMERMAN DANIEL HSenior Vice President
|
GrantOptions · Derivative | 100,000 | $0.01 Strike: $2.45 | $1,000.00 |
DisclosureSEC source: 0001236031-18-000019 · primary_doc.xml · derivative · entry 2 ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,694 Underlying: Common Stock · 100,000 shares Expires 2028-04-30 F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:41 UTC |
ZIMMERMAN DANIEL HSenior Vice President
|
GrantOptions · Derivative | 26,194 | $0.01 Strike: $2.45 | $261.94 |
DisclosureSEC source: 0001236031-18-000019 · primary_doc.xml · derivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,694 Underlying: Common Stock · 26,194 shares Expires 2028-04-30 F1 · shares: The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:35 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantOptions · Derivative | 180,000 | $0.01 Strike: $2.45 | $1,800.00 |
DisclosureSEC source: 0001236031-18-000018 · primary_doc.xml · derivative · entry 2 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,968 Underlying: Common Stock · 180,000 shares Expires 2028-04-30 F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:35 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantOptions · Derivative | 42,607 | $0.01 Strike: $2.45 | $426.07 |
DisclosureSEC source: 0001236031-18-000018 · primary_doc.xml · derivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,968 Underlying: Common Stock · 42,607 shares Expires 2028-04-30 F1 · shares: The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:28 UTC |
TALOR EYALChief Scientific Officer
|
GrantOptions · Derivative | 180,000 | $0.01 Strike: $2.45 | $1,800.00 |
DisclosureSEC source: 0001236031-18-000017 · primary_doc.xml · derivative · entry 2 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,497 Underlying: Common Stock · 180,000 shares Expires 2028-04-30 F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:28 UTC |
TALOR EYALChief Scientific Officer
|
GrantOptions · Derivative | 13,934 | $0.01 Strike: $2.45 | $139.34 |
DisclosureSEC source: 0001236031-18-000017 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,497 Underlying: Common Stock · 13,934 shares Expires 2028-04-30 F1 · shares: The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:20 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantOptions · Derivative | 370,000 | $0.01 Strike: $2.45 | $3,700.00 |
DisclosureSEC source: 0001236031-18-000016 · primary_doc.xml · derivative · entry 2 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,635,482 Underlying: Common Stock · 370,000 shares Expires 2028-04-30 F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 20:20 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantOptions · Derivative | 160,121 | $0.01 Strike: $2.45 | $1,601.21 |
DisclosureSEC source: 0001236031-18-000016 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265,482 Underlying: Common Stock · 160,121 shares Expires 2028-04-30 F1 · shares: The options were awarded in recognition of the salary that has been deferred over the last 18 months and not paid in cash. The options awarded are equal to 0.25 option for every dollar deferred. F2 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| May 01, 2018 Filed May 3, 2018 12:48 UTC |
YOUNG PETER RDirector
|
PurchaseCommon Stock | 2,000 | $2.14 | $4,280.00 |
DisclosureSEC source: 0001236031-18-000015 · primary_doc.xml · nonDerivative · entry 1 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,691 Read SEC document |
| April 27, 2018 Filed May 1, 2018 13:21 UTC |
YOUNG PETER RDirector
|
PurchaseCommon Stock | 4,000 | $2.39 | $9,540.00 |
DisclosureSEC source: 0001236031-18-000014 · primary_doc.xml · nonDerivative · entry 1 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,691 Read SEC document |
| April 16, 2018 Filed Apr 17, 2018 16:42 UTC |
YOUNG PETER RDirector
|
PurchaseCommon Stock | 4,000 | $1.80 | $7,200.00 |
DisclosureSEC source: 0001236031-18-000013 · primary_doc.xml · nonDerivative · entry 2 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,691 Read SEC document |
| April 16, 2018 Filed Apr 17, 2018 16:42 UTC |
YOUNG PETER RDirector
|
PurchaseCommon Stock | 2,500 | $1.79 | $4,475.00 |
DisclosureSEC source: 0001236031-18-000013 · primary_doc.xml · nonDerivative · entry 1 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,691 Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 14:00 UTC |
ZIMMERMAN DANIEL HSenior Vice President
|
GrantCommon Stock | 2,422 | $1.41 | $3,415.02 |
DisclosureSEC source: 0001236031-18-000012 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,980 Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 13:57 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 1,702 | $1.41 | $2,399.82 |
DisclosureSEC source: 0001236031-18-000011 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,959 Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 13:53 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantCommon Stock | 2,602 | $1.41 | $3,668.82 |
DisclosureSEC source: 0001236031-18-000010 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,236 Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 13:50 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 2,925 | $1.41 | $4,124.25 |
DisclosureSEC source: 0001236031-18-000009 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,264 Read SEC document |
| January 22, 2018 Filed Jan 22, 2018 21:47 UTC |
TALOR EYALCSO
|
SaleCommon Stock | 6,441 | $2.06 | $13,268.46 |
DisclosureSEC source: 0001236031-18-000008 · primary_doc.xml · nonDerivative · entry 2 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,257 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| January 17, 2018 Filed Jan 22, 2018 21:47 UTC |
TALOR EYALCSO
|
SaleCommon Stock | 1,751 | $2.06 | $3,607.06 |
DisclosureSEC source: 0001236031-18-000008 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,698 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| January 16, 2018 Filed Jan 18, 2018 22:05 UTC |
TALOR EYALCSO
|
SaleCommon Stock | 1,707 | $2.15 | $3,670.05 |
DisclosureSEC source: 0001236031-18-000007 · primary_doc.xml · nonDerivative · entry 2 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,449 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| January 12, 2018 Filed Jan 18, 2018 22:05 UTC |
TALOR EYALCSO
|
SaleCommon Stock | 101 | $2.15 | $217.15 |
DisclosureSEC source: 0001236031-18-000007 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,156 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 15:19 UTC |
ZIMMERMAN DANIEL HSr. Vice President
|
GrantCommon Stock | 1,807 | $1.89 | $3,415.23 |
DisclosureSEC source: 0001236031-18-000004 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,558 Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 15:14 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 1,269 | $1.89 | $2,398.41 |
DisclosureSEC source: 0001236031-18-000003 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,257 Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 15:08 UTC |
PRICHEP PATRICIA BSr. V.P. Operatioms
|
GrantCommon Stock | 1,941 | $1.89 | $3,668.49 |
DisclosureSEC source: 0001236031-18-000002 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Sr. V.P. Operatioms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,634 Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 15:02 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantCommon Stock | 2,103 | $1.89 | $3,974.67 |
DisclosureSEC source: 0001236031-18-000001 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,339 Read SEC document |
| December 18, 2017 Filed Jan 16, 2018 21:28 UTC |
Watson Robert EugeneDirector
|
GrantOptions · Derivative | 10,000 | $0.01 Strike: $1.84 | $100.00 |
DisclosureSEC source: 0001236031-18-000006 · primary_doc.xml · derivative · entry 1 Watson Robert Eugene · CIK 0001511858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-12-17 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 18:05 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantSeries RR Warrants · Derivative | 73,965 | $0.01 Strike: $1.65 | $739.65 |
DisclosureSEC source: 0001236031-17-000022 · primary_doc.xml · derivative · entry 2 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105,361 Underlying: Common Stock · 73,965 shares Expires 2022-10-30 F1 · security: In consideration for extending the maturity date of the Convertible Notes sold in June and July 2017, the Company issued the note holders that agreed to the extension Series RR warrants. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 18:05 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantSeries RR Warrants · Derivative | 54,585 | $0.01 Strike: $1.65 | $545.85 |
DisclosureSEC source: 0001236031-17-000022 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Beneficiary Disclosed balance after: 1,031,396 Underlying: Common Stock · 54,585 shares Expires 2022-10-30 F1 · security: In consideration for extending the maturity date of the Convertible Notes sold in June and July 2017, the Company issued the note holders that agreed to the extension Series RR warrants. F2 · ownership.direct: A trust in which Mr. Kersten holds a beneficial interest participated in the offering in July 2017. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 17:47 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantSeries RR Warrants · Derivative | 5,459 | $0.01 Strike: $1.65 | $54.59 |
DisclosureSEC source: 0001236031-17-000021 · primary_doc.xml · derivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,481 Underlying: Common Stock · 5,459 shares Expires 2022-10-30 F1 · security: In consideration for extending the maturity date of the Convertible Notes sold in June and July 2017, the Company issued the note holders that agreed to the extension Series RR warrants. Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 14:31 UTC |
ZIMMERMAN DANIEL HSr. Vice President
|
GrantCommon Stock | 2,058 | $1.66 | $3,416.28 |
DisclosureSEC source: 0001236215-17-000013 · primary_doc.xml · nonDerivative · entry 1 ZIMMERMAN DANIEL H · CIK 0001236028 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,751 Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 14:08 UTC |
TALOR EYALChief Scientific Officer
|
GrantCommon Stock | 1,445 | $1.66 | $2,398.70 |
DisclosureSEC source: 0001236215-17-000012 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,988 Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 14:02 UTC |
PRICHEP PATRICIA BSr. V.P. Operatioms
|
GrantCommon Stock | 2,210 | $1.66 | $3,668.60 |
DisclosureSEC source: 0001236215-17-000011 · primary_doc.xml · nonDerivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Sr. V.P. Operatioms 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,693 Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 13:56 UTC |
KERSTEN GEERT RDirector · CEO
|
GrantCommon Stock | 2,394 | $1.66 | $3,974.04 |
DisclosureSEC source: 0001236215-17-000010 · primary_doc.xml · nonDerivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,236 Read SEC document |
| September 18, 2017 Filed Oct 2, 2017 14:31 UTC |
ZIMMERMAN DANIEL HSr. Vice President
|
GrantOptions · Derivative | 20,000 | $1.59 Strike: $1.59 | $31,800.00 |
DisclosureSEC source: 0001236215-17-000013 · primary_doc.xml · derivative · entry 2 ZIMMERMAN DANIEL H · CIK 0001236028 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,668 Underlying: Common Stock · 20,000 shares Expires not disclosed F1 · derivative.expiration_date: The stock options vest in three(3) equal annual installments commencing one year after the grant date. Read SEC document |
| August 25, 2017 Filed Aug 29, 2017 21:19 UTC |
TALOR EYALChief Scientific Officer
|
SaleCommon Stock | 769 | $1.91 | $1,468.79 |
DisclosureSEC source: 0001236031-17-000020 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,543 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 21:25 UTC |
CIPRIANO JOHNSenior Vice President
|
SaleCommon Stock | 17,109 | $2.52 | $43,114.68 |
DisclosureSEC source: 0001236031-17-000019 · primary_doc.xml · nonDerivative · entry 1 CIPRIANO JOHN · CIK 0001282304 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 21:20 UTC |
TALOR EYALChief Scientific Officer
|
SaleCommon Stock | 12,000 | $2.58 | $30,960.00 |
DisclosureSEC source: 0001236031-17-000018 · primary_doc.xml · nonDerivative · entry 2 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,312 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 21:20 UTC |
TALOR EYALChief Scientific Officer
|
SaleCommon Stock | 2,019 | $2.82 | $5,693.58 |
DisclosureSEC source: 0001236031-17-000018 · primary_doc.xml · nonDerivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,312 F1 · shares: Shares were sold to pay for the taxes owed on the incentive stock bonus shares recently received that were approved by the shareholders at the 2014 Annual Shareholder Meeting. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 13:41 UTC |
BAILLAVOINE BRUNO JEAN-MARIEDirector
|
GrantOptions · Derivative | 20,000 | $0.01 Strike: $2.18 | $200.00 |
DisclosureSEC source: 0001236031-17-000017 · primary_doc.xml · derivative · entry 1 BAILLAVOINE BRUNO JEAN-MARIE · CIK 0001646989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 20,000 shares Expires 2027-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 13:36 UTC |
YOUNG PETER RDirector
|
GrantOptions · Derivative | 20,000 | $0.01 Strike: $2.18 | $200.00 |
DisclosureSEC source: 0001236031-17-000016 · primary_doc.xml · derivative · entry 1 YOUNG PETER R · CIK 0001238029 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,587 Underlying: Common Stock · 20,000 shares Expires 2027-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 13:31 UTC |
CIPRIANO JOHNSenior Vice President
|
GrantOptions · Derivative | 90,000 | $0.01 Strike: $2.18 | $900.00 |
DisclosureSEC source: 0001236031-17-000015 · primary_doc.xml · derivative · entry 1 CIPRIANO JOHN · CIK 0001282304 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,800 Underlying: Common Stock · 90,000 shares Expires 2027-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 13:27 UTC |
TALOR EYALChief Scientific Officer
|
GrantOptions · Derivative | 120,000 | $0.01 Strike: $2.18 | $1,200.00 |
DisclosureSEC source: 0001236031-17-000014 · primary_doc.xml · derivative · entry 1 TALOR EYAL · CIK 0001238028 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,860 Underlying: Common Stock · 120,000 shares Expires 2027-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 13:22 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantOptions · Derivative | 120,000 | $0.01 Strike: $2.18 | $1,200.00 |
DisclosureSEC source: 0001236031-17-000013 · primary_doc.xml · derivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,422 Underlying: Common Stock · 120,000 shares Expires 2027-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 13:16 UTC |
KERSTEN GEERT RDirector · Chief Exeuctive Officer
|
GrantOptions · Derivative | 180,000 | $0.01 Strike: $2.18 | $1,800.00 |
DisclosureSEC source: 0001236031-17-000012 · primary_doc.xml · derivative · entry 1 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Exeuctive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 977,611 Underlying: Common Stock · 180,000 shares Expires 2027-07-27 F1 · derivative.exercise_date: The stock options vest in three (3) equal annual installments commencing one year after the grant date. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 19:35 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantSeries NN Warrant · Derivative | 10,917 | $0.01 Strike: $2.52 | $109.17 |
DisclosureSEC source: 0001236031-17-000011 · primary_doc.xml · derivative · entry 2 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,422 Underlying: Common Stock · 10,917 shares Expires 2022-07-24 F1 · security: Ms. Prichep participated in an offering and purchased a note in the principal amount of $25,000, as well as the Series NN warrant. Shares issuable upon the conversion of the note or the exercise of the warrant will be restricted securities unless registered. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 19:35 UTC |
PRICHEP PATRICIA BSenior Vice President
|
GrantConvertible Note · Derivative | 10,917 | $25,000.00 Strike: $2.29 | $272,925,000.00 |
DisclosureSEC source: 0001236031-17-000011 · primary_doc.xml · derivative · entry 1 PRICHEP PATRICIA B · CIK 0001236215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,505 Underlying: Common Stock · 10,917 shares Expires 2017-12-22 F1 · security: Ms. Prichep participated in an offering and purchased a note in the principal amount of $25,000, as well as the Series NN warrant. Shares issuable upon the conversion of the note or the exercise of the warrant will be restricted securities unless registered. Read SEC document |
| July 24, 2017 Filed Jul 25, 2017 19:26 UTC |
KERSTEN GEERT RDirector · Chief Executive Officer
|
GrantSeries NN Warrant · Derivative | 109,170 | $0.01 Strike: $2.52 | $1,091.70 |
DisclosureSEC source: 0001236031-17-000010 · primary_doc.xml · derivative · entry 2 KERSTEN GEERT R · CIK 0001236030 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Beneficiary Disclosed balance after: 797,611 Underlying: Common Stock · 109,170 shares Expires 2022-07-24 F1 · ownership.direct: A trust in which Mr. Kersten holds a beneficial interest participated in an offering and purchased a note in the principal amount of $250,000 as well the Series NN warrant. Shares issuable upon the conversion of the notes or exercise of the warrant will be restricted securities unless registered. The number of securities beneficially owned gives effect to the 25-for-1 reverse stock split which became effective on June 15, 2017, and include Series N warrants (as amended) to purchase 85,339 shares of common stock held by the de Clara Trust. The amended Series N warrants expire on August 18, 2018 and are exercisable at a price of $3.00 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.